Ortho-biological management of osteonecrosis in sickle cell disease using core decompression with platelet-rich plasma: a case report
DOI:
https://doi.org/10.18203/issn.2455-4510.IntJResOrthop20261238Keywords:
Avascular necrosis, Sickle cell disease, Ficat-Aarlet, Core decompression, Platelet rich plasmaAbstract
Avascular necrosis (AVN) is a debilitating manifestation of sickle cell disease (SCD) caused due to structural abnormality of the red blood cells and the precarious blood supply of the femoral head. Prompt identification of the condition in susceptible individuals is of utmost importance. Here, we present a case of SCD with bilateral AVN in Ficat-Arlet stages IIb (left hip) and I (right hip) which was managed by core decompression augmented with platelet rich plasma.
References
Adesina O, Brunson A, Keegan THM, Wun T. Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California. Blood Adv. 2017;1(16):1287-95.
Sundd P, Gladwin MT, Novelli EM. Pathophysiology of sickle cell disease. Annu Rev Pathol. 2019;14:263-92.
Mukisi-Mukaza M, Manicom O, Alexis C, Bashoun K, Donkerwolcke M, Burny F. Treatment of sickle cell disease’s hip necrosis by core decompression: A prospective case-control study. Orthop Traumatol Surg Res. 2009;95(7):498-504.
Sierra R, Houdek M, Wyles C, Martin J. Stem cell treatment for avascular necrosis of the femoral head: current perspec tives. Stem Cells Cloning. 2014;7:65.
Martin JR, Houdek MT, Sierra RJ. Use of concentrated bone marrow aspirate and platelet rich plasma during minimally invasive decompression of the femoral head in the treatment of osteonecrosis. Croat Med J. 2013;54(3):219-24.
Aggarwal AK, Poornalingam K, Jain A, Prakash M. Com bining platelet-rich plasma instillation with core decompres sion improves functional outcome and delays progression in early-stage avascular necrosis of femoral head: A 4.5- to 6-year prospective randomized comparative study. J Arth Roplasty. 2021;36(1):54-61.